Clinical Trial Update: Clinical Trail to Evaluate the Effect of Long-term Treatment With Gecacitinib on Myelofibrosis and Gene Mutation Levels

View source ↗

Summary

This document is a clinical trial update describing a long-term study of Gecacitinib for myelofibrosis, including assessment of its effects on disease activity …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Gecacitinib (Gecacitinib)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Myelofibrosis | Status: ACTIVE_NOT_RECRUITING